BG
Bahl & Gaynor Portfolio holdings
AUM
$19.8B
1-Year Return
17.27%
This Quarter Return
+6.32%
1 Year Return
+17.27%
3 Year Return
+58.16%
5 Year Return
+110.76%
10 Year Return
+270.98%
AUM
$19.8B
AUM Growth
+$142M
(+0.72%)
Cap. Flow
-$588M
Cap. Flow
% of AUM
-2.98%
Top 10 Holdings %
Top 10 Hldgs %
32.72%
Holding
349
New
12
Increased
106
Reduced
177
Closed
17
Top Buys
| 1 |
AbbVie
ABBV
|
+$153M |
| 2 |
UnitedHealth
UNH
|
+$126M |
| 3 |
TE Connectivity
TEL
|
+$115M |
| 4 |
Johnson & Johnson
JNJ
|
+$51.8M |
| 5 |
AvalonBay Communities
AVB
|
+$49.9M |
Top Sells
| 1 |
Williams Companies
WMB
|
+$174M |
| 2 |
Travelers Companies
TRV
|
+$137M |
| 3 |
Texas Instruments
TXN
|
+$125M |
| 4 |
PepsiCo
PEP
|
+$115M |
| 5 |
Eaton
ETN
|
+$104M |
Sector Composition
| 1 | Technology | 23.93% |
| 2 | Financials | 16.28% |
| 3 | Healthcare | 14.28% |
| 4 | Industrials | 11.17% |
| 5 | Consumer Staples | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Lam Research
LRCX
$136B
| $545K | ﹤0.01% |
5,602
+102
| +2% | +$9.93K |
|
277
C.H. Robinson
CHRW
$15.1B
| $544K | ﹤0.01% |
5,670
-60
| -1% | -$5.76K |
|
278
Simpson Manufacturing
SSD
$7.97B
| $525K | ﹤0.01% |
3,383
-166
| -5% | -$25.8K |
|
279
Pool Corp
POOL
$11.9B
| $523K | ﹤0.01% |
1,795
-320
| -15% | -$93.3K |
|
280
Danaher
DHR
$138B
| $519K | ﹤0.01% |
2,627
+17
| +0.7% | +$3.36K |
|
281
McKesson
MCK
$87.8B
| $518K | ﹤0.01% |
707
| – | – |
|
282
Northern Trust
NTRS
$24.2B
| $507K | ﹤0.01% |
3,995
| – | – |
|
283
Huntington Bancshares
HBAN
$25.8B
| $494K | ﹤0.01% |
29,450
-2,970
| -9% | -$49.8K |
|
284
West Pharmaceutical
WST
$18.4B
| $465K | ﹤0.01% |
2,125
-200
| -9% | -$43.8K |
|
285
Check Point Software Technologies
CHKP
$20.9B
| $465K | ﹤0.01% |
2,100
| – | – |
|
286
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$9.84B
| $458K | ﹤0.01% |
3,405
-130
| -4% | -$17.5K |
|
287
Enterprise Products Partners
EPD
$68.5B
| $457K | ﹤0.01% |
14,751
+400
| +3% | +$12.4K |
|
288
Brown-Forman Class B
BF.B
$12.9B
| $449K | ﹤0.01% |
16,695
-1,450
| -8% | -$39K |
|
289
Synovus
SNV
$7.13B
| $446K | ﹤0.01% |
8,622
| – | – |
|
290
Vanguard Total International Stock ETF
VXUS
$103B
| $437K | ﹤0.01% |
6,323
| – | – |
|
291
Boston Scientific
BSX
$156B
| $437K | ﹤0.01% |
4,064
| – | – |
|
292
SPDR Portfolio Emerging Markets ETF
SPEM
$13.5B
| $434K | ﹤0.01% |
10,160
+1,510
| +17% | +$64.5K |
|
293
Bank of New York Mellon
BK
$73.3B
| $431K | ﹤0.01% |
4,727
+54
| +1% | +$4.92K |
|
294
OGE Energy
OGE
$8.85B
| $422K | ﹤0.01% |
9,500
| – | – |
|
295
Cigna
CI
$80.7B
| $413K | ﹤0.01% |
1,248
| – | – |
|
296
Edwards Lifesciences
EW
$46B
| $399K | ﹤0.01% |
5,098
| – | – |
|
297
Canadian Natural Resources
CNQ
$64.9B
| $381K | ﹤0.01% |
12,138
-48
| -0.4% | -$1.51K |
|
298
Conagra Brands
CAG
$9.27B
| $366K | ﹤0.01% |
17,897
-252,085
| -93% | -$5.16M |
|
299
Citigroup
C
$179B
| $358K | ﹤0.01% |
4,203
+213
| +5% | +$18.1K |
|
300
Royal Gold
RGLD
$12.3B
| $356K | ﹤0.01% |
2,000
| – | – |
|